Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > QUILT-3.032 Trial - BCG & N-803 for BCG-Unresponsive NMIBC

<< Previous

Bullboard Posts

Next >>

Comment by Tapps21on Nov 22, 2023 11:18am

248 Views

Post# 35748460

RE:RE:QUILT-3.032 Trial - BCG & N-803 for BCG-Unresponsive NMIBC

My vote goes to Eoganacht and Wildbird for our PR people. You folks sure do make Ruvidar shine. How the medical community has not caught on is anyone's guess. If and when it does, and should, this will be a superstar in the new standard of care. Jmo

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?